These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 29144541

  • 1. Genetic landscape of papillary thyroid carcinoma in the Chinese population.
    Liang J, Cai W, Feng D, Teng H, Mao F, Jiang Y, Hu S, Li X, Zhang Y, Liu B, Sun ZS.
    J Pathol; 2018 Feb; 244(2):215-226. PubMed ID: 29144541
    [Abstract] [Full Text] [Related]

  • 2. RET, NTRK, ALK, BRAF, and MET Fusions in a Large Cohort of Pediatric Papillary Thyroid Carcinomas.
    Pekova B, Sykorova V, Dvorakova S, Vaclavikova E, Moravcova J, Katra R, Astl J, Vlcek P, Kodetova D, Vcelak J, Bendlova B.
    Thyroid; 2020 Dec; 30(12):1771-1780. PubMed ID: 32495721
    [Abstract] [Full Text] [Related]

  • 3. Application value of multi-gene mutation detection in the clinical management of pediatric papillary thyroid carcinoma: a preliminary exploration.
    Wang Y, Wang H, Tan G, Wu X, Wang B, Tan Z, Du J, Li X, Xu Y, Yan N, Qian X.
    Front Endocrinol (Lausanne); 2024 Dec; 15():1405142. PubMed ID: 38904052
    [Abstract] [Full Text] [Related]

  • 4. Integrating Molecular Testing in the Diagnosis and Management of Children with Thyroid Lesions.
    Ballester LY, Sarabia SF, Sayeed H, Patel N, Baalwa J, Athanassaki I, Hernandez JA, Fang E, Quintanilla NM, Roy A, López-Terrada DH.
    Pediatr Dev Pathol; 2016 Dec; 19(2):94-100. PubMed ID: 26366474
    [Abstract] [Full Text] [Related]

  • 5. Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the BRAF V600E mutation.
    Bae JS, Kim Y, Jeon S, Kim SH, Kim TJ, Lee S, Kim MH, Lim DJ, Lee YS, Jung CK.
    Diagn Pathol; 2016 Feb 09; 11():21. PubMed ID: 26857243
    [Abstract] [Full Text] [Related]

  • 6. Papillary Thyroid Carcinoma: Correlation Between Molecular and Clinical Features.
    Wang Q, Yu B, Zhang S, Wang D, Xiao Z, Meng H, Dong L, Zhang Y, Wu J, Hou Z, Zhu Y, Li D.
    Mol Diagn Ther; 2024 Sep 09; 28(5):601-609. PubMed ID: 38896179
    [Abstract] [Full Text] [Related]

  • 7. Detection of RET rearrangements in papillary thyroid carcinoma using RT-PCR and FISH techniques - A molecular and clinical analysis.
    Musholt TJ, Staubitz JI, Antonio Cámara RJ, Musholt PB, Humberg D, Springer E, Schad A.
    Eur J Surg Oncol; 2019 Jun 09; 45(6):1018-1024. PubMed ID: 30472213
    [Abstract] [Full Text] [Related]

  • 8. Clinicopathological Features of CCDC6-RET and NCOA4-RET Fusions in Thyroid Cancer: A Single-Center Retrospective Cohort Study in a Chinese Population.
    Wang Z, Yao Q, Bao L, Chang H, Ren M, Xue T, Wei R, Yu C, Wang Q, Wang Y, Ping B, Bai Q, Zhou X, Zhu X.
    Thyroid; 2024 Oct 09; 34(10):1260-1270. PubMed ID: 39212716
    [Abstract] [Full Text] [Related]

  • 9. Oncogenic alterations in papillary thyroid cancers of young patients.
    Sassolas G, Hafdi-Nejjari Z, Ferraro A, Decaussin-Petrucci M, Rousset B, Borson-Chazot F, Borbone E, Berger N, Fusco A.
    Thyroid; 2012 Jan 09; 22(1):17-26. PubMed ID: 22150560
    [Abstract] [Full Text] [Related]

  • 10. A Narrative Review of Genetic Alterations in Primary Thyroid Epithelial Cancer.
    Romei C, Elisei R.
    Int J Mol Sci; 2021 Feb 09; 22(4):. PubMed ID: 33572167
    [Abstract] [Full Text] [Related]

  • 11. The changing characteristics and molecular profiles of papillary thyroid carcinoma over time: a systematic review.
    Vuong HG, Altibi AM, Abdelhamid AH, Ngoc PU, Quan VD, Tantawi MY, Elfil M, Vu TL, Elgebaly A, Oishi N, Nakazawa T, Hirayama K, Katoh R, Huy NT, Kondo T.
    Oncotarget; 2017 Feb 07; 8(6):10637-10649. PubMed ID: 27793009
    [Abstract] [Full Text] [Related]

  • 12. Fusion Oncogenes Are the Main Genetic Events Found in Sporadic Papillary Thyroid Carcinomas from Children.
    Cordioli MI, Moraes L, Bastos AU, Besson P, Alves MT, Delcelo R, Monte O, Longui C, Cury AN, Cerutti JM.
    Thyroid; 2017 Feb 07; 27(2):182-188. PubMed ID: 27849443
    [Abstract] [Full Text] [Related]

  • 13. Genomic characterization of high-recurrence risk papillary thyroid carcinoma in a southern Chinese population.
    Li M, Jia H, Qian Q, Wen P, Chen C, Hua Y, Wang K, Zhang W, Shi F.
    Diagn Pathol; 2020 May 11; 15(1):49. PubMed ID: 32393293
    [Abstract] [Full Text] [Related]

  • 14. Genomic landscape of metastatic papillary thyroid carcinoma and novel biomarkers for predicting distant metastasis.
    Lan X, Bao H, Ge X, Cao J, Fan X, Zhang Q, Liu K, Zhang X, Tan Z, Zheng C, Wang A, Chen C, Zhu X, Wang J, Xu J, Zhu X, Wu X, Wang X, Shao Y, Ge M.
    Cancer Sci; 2020 Jun 11; 111(6):2163-2173. PubMed ID: 32187423
    [Abstract] [Full Text] [Related]

  • 15. Identification of a Recurrent LMO7-BRAF Fusion in Papillary Thyroid Carcinoma.
    He H, Li W, Yan P, Bundschuh R, Killian JA, Labanowska J, Brock P, Shen R, Heerema NA, de la Chapelle A.
    Thyroid; 2018 Jun 11; 28(6):748-754. PubMed ID: 29768105
    [Abstract] [Full Text] [Related]

  • 16. Molecular Profiling of Papillary Thyroid Carcinoma in Korea with a High Prevalence of BRAFV600E Mutation.
    Lee SE, Hwang TS, Choi YL, Kim WY, Han HS, Lim SD, Kim WS, Yoo YB, Kim SK.
    Thyroid; 2017 Jun 11; 27(6):802-810. PubMed ID: 28293988
    [Abstract] [Full Text] [Related]

  • 17. Association between BRAF and RAS mutations, and RET rearrangements and the clinical features of papillary thyroid cancer.
    Ming J, Liu Z, Zeng W, Maimaiti Y, Guo Y, Nie X, Chen C, Zhao X, Shi L, Liu C, Huang T.
    Int J Clin Exp Pathol; 2015 Jun 11; 8(11):15155-62. PubMed ID: 26823860
    [Abstract] [Full Text] [Related]

  • 18. New somatic mutations and WNK1-B4GALNT3 gene fusion in papillary thyroid carcinoma.
    Costa V, Esposito R, Ziviello C, Sepe R, Bim LV, Cacciola NA, Decaussin-Petrucci M, Pallante P, Fusco A, Ciccodicola A.
    Oncotarget; 2015 May 10; 6(13):11242-51. PubMed ID: 25803323
    [Abstract] [Full Text] [Related]

  • 19. A Shift in Molecular Drivers of Papillary Thyroid Carcinoma Following the 2017 World Health Organization Classification: Characterization of 554 Consecutive Tumors With Emphasis on BRAF-Negative Cases.
    Hang JF, Chen JY, Kuo PC, Lai HF, Lee TL, Tai SK, Kuo CS, Chen HS, Li WS, Li CF.
    Mod Pathol; 2023 Sep 10; 36(9):100242. PubMed ID: 37307878
    [Abstract] [Full Text] [Related]

  • 20. Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China.
    Huang M, Yan C, Xiao J, Wang T, Ling R.
    Diagn Pathol; 2019 Jul 12; 14(1):74. PubMed ID: 31300059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.